Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 25, 2023
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
Patrick Trucchio Maintained (ALNY) at Strong Buy with Decreased Target to $405 on, Jul 25th, 2023
Patrick Trucchio of HC Wainwright & Co., Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Decreased Target from $415 to $405 on, Jul 25th, 2023.
Patrick has made no other calls on ALNY in the last 4 months.
There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 3 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $200 on, Thursday, July 13th, 2023
- David Hoang of "SMBC Nikko" Initiated at Hold and Held Target at $220 on, Wednesday, April 26th, 2023
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $210 on, Tuesday, April 4th, 2023
These are the ratings of the 2 analyists that currently disagree with Patrick
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Friday, May 5th, 2023
- Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $250 on, Friday, May 5th, 2023
